These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7196003)

  • 1. Azathioprine teratogenicity: review of the literature and case report.
    Williamson RA; Karp LE
    Obstet Gynecol; 1981 Aug; 58(2):247-50. PubMed ID: 7196003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azathioprine teratogenicity: review of the literature and case report.
    Gebhardt DO
    Obstet Gynecol; 1983 Feb; 61(2):270. PubMed ID: 6823371
    [No Abstract]   [Full Text] [Related]  

  • 3. Two chromosome aberrations in the child of a woman with systemic lupus erythematosus treated with azathioprine and prednisone.
    Ostrer H; Stamberg J; Perinchief P
    Am J Med Genet; 1984 Mar; 17(3):627-32. PubMed ID: 6711614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
    Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
    Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and azathioprine in systemic lupus erythrmatosus.
    Sharon E; Jones J; Diamond H; Kaplan D
    Am J Obstet Gynecol; 1974 Jan; 118(1):25-8. PubMed ID: 4808868
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic lupus erythematosus in pregnancy treated with azathioprine.
    Gillibrand PN
    Proc R Soc Med; 1966 Sep; 59(9):834. PubMed ID: 5921571
    [No Abstract]   [Full Text] [Related]  

  • 7. Teratogenic effects of first-trimester cyclophosphamide therapy.
    Kirshon B; Wasserstrum N; Willis R; Herman GE; McCabe ER
    Obstet Gynecol; 1988 Sep; 72(3 Pt 2):462-4. PubMed ID: 3136412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problems posed in research on the teratogenic properties of various antimetabolites].
    Tuchmann-Duplessis H; Mercier-Parot L
    Bull Inst Natl Sante Rech Med; 1967; 22(3):443-9. PubMed ID: 5598358
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic lupus erythematosus.
    Syrop CH; Varner MW
    Clin Obstet Gynecol; 1983 Sep; 26(3):547-57. PubMed ID: 6352122
    [No Abstract]   [Full Text] [Related]  

  • 10. [The teratogenic risk].
    Tuchmann-Duplessis H
    Arch Anat Histol Embryol; 1968; 51(5):719-25. PubMed ID: 4917890
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review.
    Khalidi NA; Rebello R; Robertson DD
    J Laryngol Otol; 2008 Dec; 122(12):1371-6. PubMed ID: 18282337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible prenatal hydantoin effect in a child born to a nonepileptic mother.
    Chodirker BN; Chudley AE; Reed MH; Persaud TV
    Am J Med Genet; 1987 Jun; 27(2):373-8. PubMed ID: 3605220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta).
    Matalon ST; Ornoy A; Lishner M
    Reprod Toxicol; 2004; 18(2):219-30. PubMed ID: 15019720
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversible posterior leukoencephalopathy caused by azathioprine in systemic lupus erythematosus.
    Foocharoen C; Tiamkao S; Srinakarin J; Chamadol N; Sawanyawisuth K
    J Med Assoc Thai; 2006 Jul; 89(7):1029-32. PubMed ID: 16881437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic fetopathy: experimental production of deformities of the extremities].
    Tuchmann-Duplessis H; Mercier-Parot L
    Union Med Can; 1968 Mar; 97(3):283-8. PubMed ID: 5741374
    [No Abstract]   [Full Text] [Related]  

  • 16. Teratogen update: azathioprine and 6-mercaptopurine.
    Polifka JE; Friedman JM
    Teratology; 2002 May; 65(5):240-61. PubMed ID: 11967923
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pregnancy and immunosuppressive agents].
    von Fischer B; Gigon U; Sidiropoulos D; Montandon A
    Gynakol Rundsch; 1981; 21(3):141-58. PubMed ID: 7019014
    [No Abstract]   [Full Text] [Related]  

  • 18. The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception.
    Nørgård B; Pedersen L; Jacobsen J; Rasmussen SN; Sørensen HT
    Aliment Pharmacol Ther; 2004 Mar; 19(6):679-85. PubMed ID: 15023170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants.
    Biggioggero M; Borghi MO; Gerosa M; Trespidi L; Cimaz R; Meroni PI
    Lupus; 2007; 16(8):651-6. PubMed ID: 17711903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?
    Enns GM; Roeder E; Chan RT; Ali-Khan Catts Z; Cox VA; Golabi M
    Am J Med Genet; 1999 Sep; 86(3):237-41. PubMed ID: 10482872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.